Clinical trial
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage…
NCT00432458 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00432458 |
|---|---|
| Title | Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma |
| Official title | A Phase III Randomized Trial of Thalidomide Plus Zoledronic Acid Versus Zoledronic Acid Alone in Patients With Early Stage Multiple Myeloma |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug |
| Interventions | Thalidomide, zoledronic acid |
| Enrollment | 68 |
| Start date | Jul 1, 2003 |
| Primary completion | Jun 1, 2011 |
| Completion | Apr 1, 2012 |
| First posted | Feb 7, 2007 |
| Last update posted | Jul 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: